[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100584117":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":19,"locations":25,"responsibleParty":58,"collaborators":62,"id":66,"slug":67,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":72,"eligibilityCriteria":73,"healthyVolunteers":68,"sex":74,"minAge":75,"maxAge":76,"enrollmentInfo":77,"targetDuration":10,"studyType":80,"phases":10,"briefSummary":81,"conditions":82,"keywords":85,"overallStatus":28,"whyStopped":10,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Aalborg University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Heart Failure Participants",null,"The included participants will be heart failure patients that are hospitalized or visits a heart failure clinic. The participants should be in NYHA Class II or higher and 18-90 years old. The participant should wear the sensor for 30 days, and it will measure every hour for the 30 days. Moreover, the participant should undergo echocardiography and answer questionnaire at enrollment day and at the last day of the study (day 30).",[13],"Other: Continuous monitroing",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Continuous monitroing","Continuous monitoring for 30 days with a small combined SCG and 1-lead ECG sensor",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Samuel Schmidt, MSc, PhD","CONTACT","+4599407456","sschmidt@hst.aau.dk",[26,44],{"facility":27,"status":28,"city":29,"state":30,"zip":31,"country":30,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"Aalborg University Hospital","RECRUITING","Aalborg","Denmark","9000","DK",{"type":34,"coordinates":35},"Point",[36,37],9.9187,57.048,{"lat":37,"lon":36},[40],{"name":41,"role":22,"phone":42,"phoneExt":10,"email":43},"Peter Søgaard, MD, DMSc","+4597664439","p.soegaard@rn.dk",{"facility":45,"status":28,"city":46,"state":30,"zip":47,"country":30,"countryCode":32,"cosmosGeoPoint":48,"geoPoint":52,"contacts":53},"Copenhagen University Hospital Herlev","Herlev","2730",{"type":34,"coordinates":49},[50,51],12.43998,55.72366,{"lat":51,"lon":50},[54],{"name":55,"role":22,"phone":56,"phoneExt":10,"email":57},"Morten K Lamberts, MD","+ 45 38 67 38 67","morten.kjoebek.lamberts@regionh.dk",{"type":59,"investigatorFullName":60,"investigatorTitle":61,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Samuel Schmidt","Associate Professor",[63,64],{"name":27,"class":6},{"name":65,"class":6},"Copenhagen University Hospital at Herlev","100584117","remote-monitoring-of-cardiac-mechanics-in-heart-failure-patients-100584117",false,"NCT06885164","Remote Monitoring of Cardiac Mechanics in Heart Failure Patients","Seismocardiographic Monitoring in Heart Failure","SeismicHeart","Inclusion Criteria:\n\n* NYHA Class II or higher\n* 18-90 years old\n\nExclusion Criteria:\n\n* Pregnancy\n* Drug addiction defined as the use of cannabis, opioids, or other drugs\n* Mechanical heart valves\n* In dialysis\n* Not possible to obtain clinical echocardiography of sufficient quality\n* Lack of ability to coorperate","ALL","18 Years","90 Years",{"count":78,"type":79},200,"ESTIMATED","OBSERVATIONAL","Heart failure is a severe heart disease, where the heart's ability to pump blood is unsatisfactory. The consequence is a high risk of hospitalization and death. Heart failure is treated with medicine which relieves symptoms and slows down the disease progression. This medical treatment needs routine adjustment, but in many cases, this adjustment is not done timely, which results in life treating conditions where the patients need acute hospitalization. Remote health monitoring of HF patients has the potential to ensure timely adjustment. However, only sensors placed inside the blood vessels of the lung, have been shown effective. The disadvantage is that the placement of the sensor requires surgery. This makes the method costly and poses a risk for the patient. The aim of the current project is to develop a small intelligent patch, which can measure the heart's function from the outside of the body. The method will be low-cost, simple to use and will not pose a risk to the patient.",[83,84],"Heart Failure","Heart Failure - NYHA II - IV",[86,87,88],"heart failure","remote monitoring","cardiac mechanics","2026-01-15",{"date":91,"type":92},"2026-01-16","ACTUAL",{"date":94,"type":92},"2025-06-11",{"date":96,"type":79},"2027-01-01",{"name":5,"class":6},2]